Enzon Pharmaceuticals Inc (NASDAQ:ENZN)

1.02
Delayed Data
As of Mar 27
 -0.01 / -0.97%
Today’s Change
0.73
Today|||52-Week Range
1.66
+3.13%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Operating ActivitiesNet Income / Starting Line177.2M-20.8M-2.8M18.2M
 
 
 
 
 
Depreciation5.8M5.3M4.3M232.0K
 
 
 
 
 
Total Other Cash Flow-168.2M5.1M16.3M-1.2M
 
 
 
 
 
Funds From Operations14.9M-10.4M17.8M17.2M
 
 
 
 
 
Funds From/For Other Operating Expenses-7.7M2.4M9.3M3.2M
 
 
 
 
 
Net Cash Flow - Operating Activities22.6M-12.7M8.5M14.0M
 
 
 
 
 
 
InvestingIncrease In Investments-2.8M-263.1M-208.3M0.00
 
 
 
 
Decrease In Investments86.3M104.4M305.8M118.9M
 
 
 
 
 
Capital Expenditures-2.0M-630.0K-23.0K0.00
 
 
 
 
Fixed Asset Disposal262.6M4.0K9.0K2.2M
 
 
 
 
 
Other Investing - Uses-105.0K0.000.000.00
 
 
Net Cash Flow Investing344.0M-159.2M97.6M121.1M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings--0.000.000.00--
Long Term Debt Reduction0.00-5.0M-13.9M-115.8M
 
 
 
 
Net Proceeds Stock Sale32.3M5.9M130.0K12.0K
 
 
 
 
 
Common Preferred Redeemed-48.2M-120.8M-31.7M0.00
 
 
 
 
Common Dividends0.000.00-87.3M-89.8M
 
 
 
Cash Dividends Paid - Total0.000.00-87.3M-89.8M
 
 
 
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing3.6M1.3M161.0K316.0K
 
 
 
 
 
Net Cash Flow - Financing-19.5M-121.2M-133.0M-206.0M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----0.000.00--
 
Net Change In Cash347.1M-293.2M-27.0M-70.8M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account